Range
7.24 - 7.41
Vol / Avg.
152.4K/422.2K
Div / Yield
-
52 Wk
7.16 - 20.07
Mkt Cap
307.4M
Payout Ratio
-
Open
7.33
P/E
-
EPS
-0.73
Shares
41.8M
Outstanding
41.8M
Total Float
31.4M
Sector: Health Care.Industry: Biotechnology
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-01, AVR-RD-02, AVR-RD-03, and AVR-RD-04 which are used for various diseases such as Fabry, Gaucher, Pompe, and Cystinosis.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-13
REV
Q1 2021Est.ActualSurprise
EPS-0.770-0.650 0.1200
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
AVROAvrobio0%307.4M

Avrobio Frequently Asked Questions

Q

How do I buy Avrobio (AVRO) stock?

A

You can purchase shares of Avrobio (NASDAQ: AVRO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Avrobio's (AVRO) competitors?

Q

What is the target price for Avrobio (AVRO) stock?

A

The latest price target for Avrobio (NASDAQ: AVRO) was reported by Morgan Stanley on July 16, 2021. The analyst firm set a price target for 29.00 expecting AVRO to rise to within 12 months (a possible 294.02% upside). 9 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Avrobio (AVRO)?

A

The stock price for Avrobio (NASDAQ: AVRO) is $7.36 last updated Today at 8:00:03 PM.

Q

Does Avrobio (AVRO) pay a dividend?

A

There are no upcoming dividends for Avrobio.

Q

When is Avrobio (NASDAQ:AVRO) reporting earnings?

A
Avrobio’s Q2 earnings are confirmed for after-market on August 13, 2021.
Q

Is Avrobio (AVRO) going to split?

A

There is no upcoming split for Avrobio.

Q

What sector and industry does Avrobio (AVRO) operate in?

A

Avrobio is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.